A carregar...
Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
OBJECTIVE: Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis. In May 2018, denosumab was approved for the treatment of GIOP in men and women at high risk of fracture. We undertook a systematic review and meta-analysis to summarize the efficacy and safety of...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6698580/ https://ncbi.nlm.nih.gov/pubmed/31616133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S148654 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|